AIM
ONC icon

Achmea Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Achmea Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,530
Closed -$681K – 327
2020
Q1 		$681K Buy
5,530
+2,939
+113% +$460K 0.03% 202
2019
Q4 		$429K Buy
+2,591
New +$430K 0.02% 482
2019
Q3 		– Sell
-4,004
Closed -$496K – 531
2019
Q2 		$496K Buy
+4,004
New +$508K 0.02% 447

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Achmea Investment Management's ONC Position: Q2 2020 in Review

Achmea Investment Management sold out of BeOne Medicines Ltd (ONC) in Q2 2020, closing a stake of 5,530 shares — an estimated $681K sold.

Achmea Investment Management first reported a position in ONC in Q2 2019 and held it in 3 quarters. The position peaked at $681K in Q1 2020. 220 funds tracked by Wall St. Rank hold ONC as of Q2 2020.

  • Achmea Investment Management reported no remaining BeOne Medicines Ltd position as of Q2 2020 after selling out during the quarter.
  • Achmea Investment Management sold 5,530 BeOne Medicines Ltd shares in Q2 2020, an estimated $681K.
  • Achmea Investment Management first reported a position in BeOne Medicines Ltd in Q2 2019 and held it in 3 quarters.
  • Achmea Investment Management's BeOne Medicines Ltd position peaked at $681K in Q1 2020.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2020.

Based on Achmea Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.